Johannes Kirchmair

Prof. Dr. Johannes Kirchmair

Department of Pharmaceutical Chemistry, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2015 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
Johannes KirchmairJohannes Kirchmair
Johannes Kirchmair
AGAndreas H. Göller
Andreas H. Göller
DLDieter Lang
Dieter Lang
JKJens Kunze
Jens Kunze
BTBernard Testa
Bernard Testa
GSGisbert Schneider
Gisbert Schneider

15 January 2008 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Closed access
PDF file
Johannes KirchmairJohannes Kirchmair
Johannes Kirchmair
PMPatrick Markt
Patrick Markt
SDSimona Distinto
Simona Distinto
GWGerhard Wolber
Gerhard Wolber
TLThierry Langer
Thierry Langer

17 February 2012 in Journal of Chemical Information and Modeling
Verified
Journal Article
Open access
Johannes KirchmairJohannes Kirchmair
Johannes Kirchmair
MWMark J. Williamson
Mark J. Williamson
JTJonathan Tyzack
Jonathan Tyzack
LTLu Tan
Lu Tan
PBPeter Bond
Peter Bond
RGRobert Glen
Robert Glen
Metabolism of xenobiotics remains a central challenge for the discovery and development of drugs, cosmetics, nutritional supplements, and agrochemicals. Metabolic transformations are frequently related to the incidence of toxic effects that may result from the emergence of reactive species, the systemic accumulation of metabolites, or by induction of metabolic pathways. Experimental investigation of the metabolism of small organic molecules is particularly resource demanding; hence, computational methods are of considerable interest to complement experimental approaches. This review provides a broad overview of structure- and ligand-based computational methods for the prediction of xenobiotic metabolism. Current computational approaches to address xenobiotic metabolism are discussed from three major perspectives: (i) prediction of sites of metabolism (SOMs), (ii) elucidation of potential metabolites and their chemical structures, and (iii) prediction of direct and indirect effects of xenobiotics on metabolizing enzymes, where the focus is on the cytochrome P450 (CYP) superfamily of enzymes, the cardinal xenobiotics metabolizing enzymes. For each of these domains, a variety of approaches and their applications are systematically reviewed, including expert systems, data mining approaches, quantitative structure–activity relationships (QSARs), and machine learning-based methods, pharmacophore-based algorithms, shape-focused techniques, molecular interaction fields (MIFs), reactivity-focused techniques, protein–ligand docking, molecular dynamics (MD) simulations, and combinations of methods. Predictive metabolism is a developing area, and there is still enormous potential for improvement. However, it is clear that the combination of rapidly increasing amounts of available ligand- and structure-related experimental data (in particular, quantitative data) with novel and diverse simulation and modeling approaches is accelerating the development of effective tools for prediction of in vivo metabolism, which is reflected by the diverse and comprehensive data sources and methods for metabolism prediction reviewed here. This review attempts to survey the range and scope of computational methods applied to metabolism prediction and also to compare and contrast their applicability and performance.

1 November 2011 in Journal of Proteomics
Verified
Journal Article
Closed access
AKAlexios Koutsoukas
Alexios Koutsoukas
BSBenjamin Simms
Benjamin Simms
Johannes KirchmairJohannes Kirchmair
Johannes Kirchmair
PBPeter Bond
Peter Bond
AWAlan V. Whitmore
Alan V. Whitmore
ABAndreas Bender
Andreas Bender

24 November 2018 in Chemical Biology & Drug Design
Verified
Journal Article
Open access
PDF file
JTJonathan Tyzack
Jonathan Tyzack
Johannes KirchmairJohannes Kirchmair
Johannes Kirchmair
In this review, we present important, recent developments in the computational prediction of cytochrome P450 (CYP) metabolism in the context of drug discovery. We discuss in silico models for the various aspects of CYP metabolism prediction, including CYP substrate and inhibitor predictors, site of metabolism predictors (i.e., metabolically labile sites within potential substrates) and metabolite structure predictors. We summarize the different approaches taken by these models, such as rule‐based methods, machine learning, data mining, quantum chemical methods, molecular interaction fields, and docking. We highlight the scope and limitations of each method and discuss future implications for the field of metabolism prediction in drug discovery.

18 February 2009 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
Johannes KirchmairJohannes Kirchmair
Johannes Kirchmair
SDSimona Distinto
Simona Distinto
PMPatrick Markt
Patrick Markt
DSDaniela Schuster
Daniela Schuster
GSGudrun M. Spitzer
Gudrun M. Spitzer
GWGerhard Wolber
Gerhard Wolber